Methods for noninvasive imaging of tissue hypoxia

Antioxidants and Redox Signaling

Volumn 9, Issue 10, 2007, Pages 1745-1756

  Vikram, Deepti S ^a   Zweier, Jay L ^a   Kuppusamy, Periannan ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 2 NITROIMIDAZOLE; ETANIDAZOLE; HEXAFLUOROBENZENE; LITHIUM; PHTHALOCYANINE; TRACER;

BRAIN; COMPUTER ASSISTED TOMOGRAPHY; ELECTRON SPIN RESONANCE; FIBROSARCOMA; HUMAN; HYPOXEMIA; IMAGING; LYMPHOMA; MICHAELIS CONSTANT; NEAR INFRARED SPECTROSCOPY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PHOSPHORESCENCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETINA; REVIEW; SIGNAL NOISE RATIO; TISSUE OXYGENATION;

ANOXIA; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; MAGNETIC RESONANCE IMAGING; OXYGEN; POSITRON-EMISSION TOMOGRAPHY;

EID: 34648843046     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1717     Document Type: Review

References (99)

1. Abele D. Toxic oxygen: the radical life-giver. Nature 420: 27, 2002.
2. Ahmad R, Clymer B, Deng Y, He G, Vikram D, Kuppusamy P, and Zweier JL. Optimization of data acquisition for EPR imaging. J Magn Reson 179: 263-272, 2006.
3. Ahmad R, Deng Y, Vikram DS, Clymer B, Srinivasan P, Zweier JL, and Kuppusamy P. Quasi Monte Carlo-based isotropic distribution of gradient directions for improved reconstruction quality of 3D EPR imaging. J Magn Reson 184: 246-257, 2007..
4. Al-Hallaq HA, River JN, Zamora M, Oikawa H, and Karczmar GS. Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int J Radiat Oncol Biol Phys 41: 151-159, 1998.
5. Alavi A. PET imaging II. Radiol Clin North Am 43: xiii-xv, 2005.
6. 2) inside tumors? Magn Reson Med 48: 980-986, 2002.
7. Bentzen L, Keiding S, Horsman MR, Gronroos T, Hansen SB, and Overgaard J. Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing. Acta Oncol 41: 304-312, 2002.
8. Bentzen L, Keiding S, Nordsmark M, Falborg L, Hansen SB, Keller J, Nielsen OS, and Overgaard J. Tumour oxygenation assessed by 18F- fluoromisonidazole PET and Polarographic needle electrodes in human soft tissue tumours. Radiother Oncol 67: 339-344, 2003.
9. Boushel R, Langberg H, Olesen J, Gonzales-Alonzo J, Bulow J, and Kjaer M. Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease. Scand J Med Sci Sports 11: 213-222, 2001.
10. Boushel R and Piantadosi CA. Near-infrared spectroscopy for monitoring muscle oxygenation. Acta Physiol Scand 168: 615-622, 2000.
11. Brizel DM, Rosner GL, Prosnitz LR, and Dewhirst MW. Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. Int J Radiat Oncol Biol Phys 32: 1121-1125, 1995.
12. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, and Dewhirst MW. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56: 941-943, 1996.
13. Busse LJ, Pratt RG, and Thomas SR. Deconvolution of chemical shift spectra in two- or three-dimensional [19F] MR imaging. J Comput Assist Tomogr 12: 824-835, 1988.
14. Cater DB and Silver IA. Quantitative measurements of oxygen tension in normal tissues and in the tumours of patients before and after radiotherapy. Acta Radiol 53: 233-256, 1960.
15. Chance B, Luo Q, Nioka S, Alsop DC, and Detre JA. Optical investigations of physiology: a study of intrinsic and extrinsic biomedical contrast. Philos Trans R Soc Lond B Biol Sci 352: 707-716, 1997.
16. Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, and Hanks GE. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother Oncol 46: 229-237, 1998.
17. Clarkson AN, Sutherland BA, and Appleton I. The biology and pathology of hypoxia-ischemia: an update. Arch Immunol Ther Exp (Warsz) 53: 213-225, 2005.
18. Deng Y, He G, Petryakov S, Kuppusamy P, and Zweier JL. Fast EPR imaging at 300 MHz using spinning magnetic field gradients. J Magn Reson 168: 220-227, 2004.
19. Dewhirst MW, Klitzman B, Braun RD, Brizel DM, Haroon ZA, and Secomb TW. Review of methods used to study oxygen transport at the microcirculatory level. Int J Cancer 90: 237-255, 2000.
20. Dubois L, Landuyt W, Haustermans K, Dupont P, Bormans G, Vermaelen P, Flamen P, Verbeken E, and Mortelmans L. Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry. Br J Cancer 91: 1947-1954, 2004.
21. Dunn JF and Swartz HM. In vivo electron paramagnetic resonance oximetry with particulate materials. Methods 30: 159-166, 2003.
22. Dunn JF, Zaim-Wadghiri Y, Pogue BW, and Kida I. BOLD MRI vs. NIR spectrophotometry. Will the best technique come forward? Adv Exp Med Biol 454: 103-113, 1998.
23. Elas M, Ahn KH, Parasca A, Barth ED, Lee D, Haney C, and Halpern HJ. Electron paramagnetic resonance oxygen images correlate spatially and quantitatively with Oxylite oxygen measurements. Clin Cancer Res 12: 4209-4217, 2006.
24. Elas M, Williams BB, Parasca A, Mailer C, Pelizzari CA, Lewis MA, River JN, Karczmar GS, Barth ED, and Halpern HJ. Quantitative tumor oxymetric images from 4D electron paramagnetic resonance imaging (EPRI): methodology and comparison with blood oxygen level-dependent (BOLD) MRI. Magn Reson Med 49: 682-691, 2003.
25. Eschmann SM, Paulsen F, Reimold M, Dittmann H, Welz S, Reischl G, Machulla HJ, and Bares R. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46: 253-260, 2005.
26. Fukumura D, Xu L, Chen Y, Gohongi T, Seed B, and Jain RK. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 61: 6020-6024, 2001.
27. Gallez B, Baudelet C, and Jordan BF. Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications. WMR Biomed 17: 240-262, 2004.
28. Graham MM, Peterson LM, Link JM, Evans ML, Rasey JS, Koh WJ, Caldwell JH, and Krohn KA. Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies. J Nucl Med 38: 1631-1636, 1997.
29. He G, Samouilov A, Kuppusamy P, and Zweier JL. In vivo EPR imaging of the distribution and metabolism of nitroxide radicals in human skin. J Magn Reson 148: 155-164, 2001.
30. Hebden JC, Gibson A, Yusof RM, Everdell N, Hillman EM, Delpy DT, Arridge SR, Austin T, Meek JH, and Wyatt JS. Three-dimensional optical tomography of the premature infant brain. Phys Med Biol 47: 4155-4166, 2002.
31. Hicks RJ, Rischin D, Fisher R, Binns D, Scott AM, and Peters LJ. Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent. Eur J Nucl Med Mol Imaging 32: 1384-1391, 2005.
32. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26: 45-50, 1993.
33. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, and Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56: 4509-4515, 1996.
34. Ilangovan G, Bratasz A, Li H, Schmalbrock P, Zweier JL, and Kuppusamy P. In vivo measurement and imaging of tumor oxygenation using coembedded paramagnetic particulates. Magn Reson Med 52: 650-657, 2004.
35. Ilangovan G, Zweier JL, and Kuppusamy P. Mechanism of oxygen-induced EPR line broadening in lithium phthalocyanine microcrystals. J Magn Reson 170: 42-48, 2004.
36. Intes X and Chance B. Non-PET functional imaging techniques: optical. Radiol Clin North Am 43: 221-234, xii, 2005.
37. Jobsis FF. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 198: 1264-1267, 1977.
38. Kida I, Yamamoto T, and Tamura M. Interpretation of BOLD MRI signals in rat brain using simultaneously measured near-infrared spectrophotometric information. NMR Biomed 9: 333-338, 1996.
39. Kirkpatrick PJ, Lam J, Al-Rawi P, Smielewski P, and Czosnyka M. Defining thresholds for critical ischemia by using near-infrared spectroscopy in the adult brain. J Neurosurg 89: 389-394, 1998.
40. Koch CJ and Evans SM. Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles. Adv Exp Med Biol 510: 285-292, 2003.
41. Koh WJ, Bergman KS, Rasey JS, Peterson LM, Evans ML, Graham MM, Grierson JR, Lindsley KL, Lewellen TK, Krohn KA, et al. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys 33: 391-398, 1995.
42. Koh WJ, Rasey JS, Evans ML, Grierson JR, Lewellen TK, Graham MM, Krohn KA, and Griffin TW. Imaging of hypoxia in human tumors with [F-18] fluoromisonidazole. Int J Radiat Oncol Biol Phys 22: 199-212, 1992.
43. Kolstad P. Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand J Clin Lab Invest Suppl 106: 145-157, 1968.
44. Krause BJ, Beck R, Souvatzoglou M, and Piert M. PET and PET/CT studies of tumor tissue oxygenation. Q J Nucl Med Mol Imaging 50: 28-43, 2006.
45. Krishna MC, English S, Yamada K, Yoo J, Murugesan R, Devasahayam N, Cook JA, Golman K, Ardenkjaer-Larsen JH, Subramanian S, and Mitchell JB. Overhauser enhanced magnetic resonance imaging for tumor oximetry: coregistration of tumor anatomy and tissue oxygen concentration. Proc Natl Acad Sci USA 99: 2216-2221, 2002.
46. Kuppusamy P, Chzhan M, Wang P, and Zweier JL. Three-dimensional gated EPR imaging of the beating heart: time-resolved measurements of free radical distribution during the cardiac contractile cycle. Magn Reson Med 35: 323-328, 1996.
47. Kuppusamy P, Shankar RA, and Zweier JL. In vivo measurement of arterial and venous oxygenation in the rat using 3D spectral-spatial electron paramagnetic resonance imaging. Phys Med Biol 43: 1837-1844, 1998.
48. Liebgott T, Li H, Deng Y, and Zweier JL. Proton electron double resonance imaging (PEDRI) of the isolated beating rat heart. Magn Reson Med 50: 391-399, 2003.
49. Lo LW, Jenkins WT, Vinogradov SA, Evans SM, and Wilson DF. Oxygen distribution in the vasculature of mouse tissue in vivo measured using a near infra red phosphor. Adv Exp Med Biol 411: 577-583, 1997.
50. Loi S, Ngan SY, Hicks RJ, Mukesh B, Mitchell P, Michael M, Zalcberg J, Leong T, Lim-Joon D, Mackay J, and Rischin D. Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial. Br J Cancer 92: 655-661, 2005.
51. Mannan RH, Somayaji VV, Lee J, Mercer JR, Chapman JD, and Wiebe LI. Radioiodinated 1-(5-iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (iodoazomycin arabinoside: IAZA): a novel marker of tissue hypoxia. J Nucl Med 32: 1764-1770, 1991.
52. Mariani E, Polidori MC, Cherubini A, and Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 827: 65-75, 2005.
53. Mason RP. Non-invasive assessment of kidney oxygenation: a role for BOLD MRI. Kidney Int 70: 10-11, 2006.
54. Mason RP, Antich PP, Babcock EE, Constantinescu A, Peschke P, and Hahn EW. Non-invasive determination of tumor oxygen tension and local variation with growth. Int J Radiat Oncol Biol Phys 29: 95-103, 1994.
55. Mason RP, Constantinescu A, Hunjan S, Le D, Hahn EW, Antich PP, Blum C, and Peschke P. Regional tumor oxygenation and measurement of dynamic changes. Radiat Res 152: 239-249, 1999.
56. 19F NMR indicator of tumor oxygenation. NMR Biomed 9: 125-134, 1996.
57. McIntyre DJO, McCoy,C.L and Griffiths,J.R. Tumor oxygenation measurements by 19F MRI of perflurocarbons. Current Science 76: 753-762, 1999.
58. Obata A, Yoshimoto M, Kasamatsu S, Naiki H, Takamatsu S, Kashikura K, Furukawa T, Lewis JS, Welch MJ, Saji H, Yonekura Y, and Fujibayashi Y. Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG. Nucl Med Biol 30: 529-534, 2003.
59. Ogawa S and Lee TM. Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation. Magn Reson Med 16: 9-18, 1990.
60. Ogawa S, Lee TM, Kay AR, and Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 87: 9868-9872, 1990.
61. Okunieff P, Ding I, Vaupel P, and Hockel M. Evidence for and against hypoxia as the primary cause of tumor aggressiveness. Adv Exp Med Biol 510: 69-75, 2003.
62. Piert M, Machulla H, Becker G, Stahlschmidt A, Patt M, Aldinger P, Dissmann PD, Fischer H, Bares R, Becker HD, and Lauchart W. Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia. Eur J Nucl Med 26: 95-109, 1999.
63. Piert M, Machulla HJ, Becker G, Aldinger P, Winter E, and Bares R. Dependency of the [18F]fluoromisonidazole uptake on oxygen delivery and tissue oxygenation in the porcine liver. Nucl Med Biol 27: 693-700, 2000.
64. Punwani S, Cooper CE, Clemence M, Penrice J, Amess P, Thornton J, and Ordidge RJ. Correlation between absolute deoxyhaemoglobin [dHb] measured by near infrared spectroscopy (NIRS) and absolute R2′ as determined by magnetic resonance imaging (MRI). Adv Exp Med Biol 413: 129-137, 1997.
65. Rajendran JG, Wilson DC, Conrad EU, Peterson LM, Bruckner JD, Rasey JS, Chin LK, Hofstrand PD, Grierson JR, Eary JF, and Krohn KA. [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging 30: 695-704, 2003.
66. Rasey JS, Koh WJ, Evans ML, Peterson LM, Lewellen TK, Graham MM, and Krohn KA. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 36: 417-428, 1996.
67. Rasey JS, Nelson NJ, Chin L, Evans ML, and Grunbaum Z. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro. Radiat Res 122: 301-308, 1990.
68. 19F nuclear magnetic resonance methodologies for the assessment of tumour hypoxia. Philos Trans R Soc Lond B Biol Sci 359: 987-996, 2004.
69. Rumsey WL, Pawlowski M, Lejavardi N, and Wilson DF. Oxygen pressure distribution in the heart in vivo and evaluation of the ischemic "border zone". Am J Physiol 266: H1676-1680, 1994.
70. Rumsey WL, Vanderkooi JM, and Wilson DF. Imaging of phosphorescence: a novel method for measuring oxygen distribution in perfused tissue. Science 241: 1649-1651, 1988.
71. Shonat RD and Norige AS. Developing strategies for three-dimensional imaging of oxygen tension in the rodent retina. Adv Exp Med Biol 566: 173-178, 2005.
72. Stankovic MR, Maulik D, Rosenfeld W, Stubblefield PG, Kofinas AD, Gratton E, Franceschini MA, Fantini S, and Hueber DM. Role of frequency domain optical spectroscopy in the detection of neonatal brain hemorrhage - a newborn piglet study. J Matern Fetal Med 9: 142-149, 2000.
73. Stubbs M. Application of magnetic resonance techniques for imaging tumour physiology. Acta Oncol 38: 845-853, 1999.
74. Swartz HM. Using EPR to measure a critical but often unmeasured component of oxidative damage: oxygen. Antioxid Redox Signal 6: 677-686, 2004.
75. Swartz HM and Dunn JF. Measurements of oxygen in tissues: overview and perspectives on methods. Adv Exp Med Biol 530: 1-12, 2003.
76. Thulborn KR, Waterton JC, Matthews PM, and Radda GK. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta 714: 265-270, 1982.
77. Tumkur SM, Vu AT, Li LP, Pierchala L, and Prasad PV. Evaluation of intra-renal oxygenation during water diuresis: a time-resolved study using BOLD MRI. Kidney Int 70: 139-143, 2006.
78. Turner R, Le Bihan D, Moonen CT, Despres D, and Frank J. Echoplanar time course MRI of cat brain oxygenation changes. Magn Reson Med 22: 159-166, 1991.
79. Vaupel P, Mayer A, and Hockel M. Tumor hypoxia and malignant progression. Methods Enzymol 381: 335-354, 2004.
80. Vaupel P, Schlenger K, Knoop C, and Hockel M. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 51: 3316-3322, 1991.
81. Velan SS, Spencer RG, Zweier JL, and Kuppusamy P. Electron paramagnetic resonance oxygen mapping (EPROM): direct visualization of oxygen concentration in tissue. Magn Reson Med 43: 804-809, 2000.
82. Vinogradov SA, Fernandez-Seara MA, Dupan BW, and Wilson DF. A method for measuring oxygen distributions in tissue using frequency domain phosphorometry. Comp Biochem Physiol A Mol Integr Physiol 132: 147-152, 2002.
83. Vinogradov SA, Fernandez-Seara,M.A. and Wilson,D.F. Frequency domain instrument for measuring phosphorescence lifetime distributions in heterogenous samples. Rev Sci Instr 72: 3396-3406, 2001.
84. Vinogradov SA, Grosul P, Rozhkov V, Dunphy I, Shuman L, Dugan BW, Evans S, and Wilson DF. Oxygen distributions in tissue measured by phosphorescence quenching. Adv Exp Med Biol 510: 181-185, 2003.
85. Vinogradov SA, Lo LW, Jenkins WT, Evans SM, Koch C, and Wilson DF. Noninvasive imaging of the distribution in oxygen in tissue in vivo using near-infrared phosphors. Biophys J 70: 1609-1617, 1996.
86. Williams BB, al Hallaq H, Chandramouli GV, Barth ED, Rivers JN, Lewis M, Galtsev VE, Karczmar GS, and Halpern HJ. Imaging spin probe distribution in the tumor of a living mouse with 250 MHz EPR: correlation with BOLD MRI. Magn Reson Med 47: 634-638, 2002.
87. Wilson DF and Cerniglia GJ. Localization of tumors and evaluation of their state of oxygenation by phosphorescence imaging. Cancer Res 52: 3988-3993, 1992.
88. Wilson DF and Cerniglia GJ. Oxygenation of tumors as evaluated by phosphorescence imaging. Adv Exp Med Biol 345: 539-547, 1994.
89. Wilson DF, Pastuszko A, DiGiacomo JE, Pawlowski M, Schneiderman R, and Delivoria-Papadopoulos M. Effect of hyperventilation on oxygenation of the brain cortex of newborn piglets. J Appl Physiol 70: 2691-2696, 1991.
90. Wilson DF, Vinogradov S, Lo LW, and Huang L. Oxygen dependent quenching of phosphorescence: a status report. Adv Exp Med Biol 388: 101-107, 1996.
91. Wilson DF, Vinogradov SA, Grosul P, Kuroki A, and Bennett J. Imaging oxygen pressure in the retina of the mouse eye. Adv Exp Med Biol 566: 159-165, 2005.
92. Wilson DF, Vinogradov SA, Grosul P, Vaccarezza MN, Kuroki A, and Bennett J. Oxygen distribution and vascular injury in the mouse eye measured by phosphorescence-lifetime imaging. Appl Opt 44: 5239-5248, 2005.
93. 19F magnetic resonance imaging in rats. Phys Med Biol 51: 45-60, 2006.
94. Yamada K, Murugesan R, Devasahayam N, Cook JA, Mitchell JB, Subramanian S, and Krishna MC. Evaluation and comparison of pulsed and continuous wave radiofrequency electron paramagnetic resonance techniques for in vivo detection and imaging of free radicals. J Magn Reson 154: 287-297, 2002.
95. Yeh SH, Liu RS, Wu LC, Yang DJ, Yen SH, Chang CW, Yu TW, Chou KL, and Chen KY. Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma. Eur J Nucl Med 23: 1378-1383, 1996.
96. 19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance. Curr Med Chem 12: 819-848, 2005.
97. Zanzonico P, O'Donoghue J, Chapman JD, Schneider R, Cai S, Larson S, Wen B, Chen Y, Finn R, Ruan S, Gerweck L, Humm J, and Ling C. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning. Eur J Nucl Med Mol Imaging 31: 117-128, 2004.
98. Zhao D, Constantinescu A, Chang CH, Hahn EW, and Mason RP. Correlation of tumor oxygen dynamics with radiation response of the dunning prostate R3327-HI tumor. Radiat Res 159: 621-631, 2003.
99. Zhao D, Constantinescu A, Hahn EW, and Mason RP. Tumor oxygen dynamics with respect to growth and respiratory challenge: investigation of the Dunning prostate R3327-HI tumor. Radiat Res 156: 510-520, 2001.